文献速递针灸推拿中医内科

艾灸对类风湿关节炎患者压痛阈值及血清P物质和白三烯B4的影响

The efficacy of moxibustion on the pressure pain threshold and substance P / leukotriene B4 contents in serum to patients with rheumatoid arthritis.
PubMed 文献 · Complement Ther Med · 2025-05-26

72例RA患者随机分为对照组(常规药物)和治疗组(常规药物+艾灸),治疗8周。第4周时治疗组在指间关节压痛阈值变化、SP、LTB4、TNF-α、IL-1β、疼痛关节数、肿胀关节数、VAS及DAS28变化上均优于对照组;治疗组指间关节压痛阈值变化与SP变化呈显著负相关。结论:艾灸联合常规西药可改善压痛阈值、缓解症状、降低疾病活动度,机制可能与下调SP、LTB4及减少IL-1β、TNF-α释放有关。

要点

  • 艾灸联合常规西药可显著提高RA患者指间关节压痛阈值并改善临床症状。
  • 艾灸可能通过下调血清SP、LTB4及减少IL-1β、TNF-α释放发挥镇痛抗炎作用。
  • 治疗组指间关节压痛阈值变化与SP变化呈显著负相关(r<0,P<0.05)。

核心结论

  • 艾灸联合常规西药可显著改善RA患者受累关节压痛阈值、缓解临床症状并降低疾病活动度。
  • 潜在机制可能与艾灸下调SP和LTB4水平、减少炎症因子IL-1β和TNF-α释放有关。

研究设计与样本

  • 随机对照试验,共72例RA患者随机等分为对照组和治疗组,最终66例完成试验(治疗组脱落1例,对照组排除和脱落5例)。
  • 对照组接受常规药物治疗,治疗组接受常规药物加艾灸治疗,两组均治疗8周。

主要发现

  • 第4周时治疗组ΔPPTs指间关节为1301.71(95%CI 967.43-1636.00),对照组为443.23(95%CI 99.51-786.95)。
  • 治疗组ΔSP为10.11(95%CI 5.85-14.37),对照组为3.10(95%CI -1.13-7.34);ΔLTB4为13.17(95%CI 7.81-18.54),对照组为3.37(95%CI -5.73-12.48)。
  • 治疗组ΔTNF-α为4.57(95%CI 2.60-6.55),对照组为0.68(95%CI -1.03-2.40);ΔIL-1β为4.63(95%CI 2.59-6.66),对照组为1.63(95%CI -0.53-3.80)。
  • 治疗组ΔPJC为7.14(95%CI 5.17-8.58),对照组为1.84(95%CI 0.66-3.02);ΔSJC为5.20(95%CI 3.44-6.96),对照组为1.00(95%CI 0.02-1.98)。
  • 治疗组ΔVAS为3.6(95%CI 2.99-4.21),对照组为0.9(95%CI 0.24-1.57);ΔDAS为1.68(95%CI 1.44-1.92),对照组为0.41(95%CI 0.08-0.73)。

临床怎么用

  • 对RA患者在常规西药治疗基础上可考虑联合艾灸,以改善关节压痛阈值和临床症状。
  • 艾灸可能通过下调SP、LTB4及炎症因子IL-1β、TNF-α发挥辅助抗炎镇痛作用。

局限性

  • 研究缺乏双盲设计,作者计划在后续试验中设立假艾灸组以避免该局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To observe the effects of moxibustion on pressure-pain thresholds (PPTs) in affected joints and non-joint areas, as well as the contents of substance P (SP) and leukotriene B4 (LTB4) in serum of patients with rheumatoid arthritis (RA), and to explore the analgesic mechanism of moxibustion in RA patients. METHODS: A total of 72 patients with RA were randomly and equally classified into the control and treatment groups. The control group was treated with routine drug therapy, while the treatment group received routine drug therapy and moxibustion. Both groups were treated for 8 weeks. The symptoms, measured by PPTs, Visual analogue scale (VAS), pain joint count (PJC), swollen joint count (SJC) and disease activity score of 28 joints (DAS28), and laboratory indicators, measured by the level of SP, LTB4, tumor necrosis factor- α (TNF-α) and interleukin-1β (IL-1β), were compared in the two groups before and after intervention. RESULTS: A total of 66 patients completed the trial, with 1 patients dropping out from the treatment group and 5 patients being excluded and dropped from the control group. Trial endpoints were change (∆) in symptoms and laboratory indicators. The treatment group showed superior in ∆PPTs of the interphalangeal joints(1301.71 (95 %CI, 967.43-1636.00) vs 443.23(95 %CI, 99.51-786.95)), ∆SP(10.11 (95 %CI, 5.85-14.37) vs 3.10 (95 %CI, -1.13-7.34)), ∆ LTB4(13.17 (95 %CI, 7.81-18.54) vs 3.37 (95 %CI, -5.73-12.48)), ∆TNF-α(4.57 (95 %CI, 2.60-6.55) vs 0.68 (95 %CI, -1.03-2.40)), ∆IL-1β(4.63 (95 %CI, 2.59-6.66) vs 1.63 (95 %CI, -0.53-3.80)), ∆PJC(7.14 (95 %CI, 5.17-8.58) vs 1.84 (95 %CI, 0.66-3.02)), ∆SJC(5.20 (95 %CI, 3.44-6.96) vs 1.00(95 %CI, 0.02-1.98)), ∆VAS(3.6 (95 %CI, 2.99-4.21) vs 0.9 (95 %CI, 0.24-1.57)), and ∆DAS(1.68 (95 %CI, 1.44-1.92) vs 0.41 (95 %CI, 0.08-0.73)) compared to the control group, at weeks 4. Furthermore, there was a significant negative correlation between ∆PPTs of the interphalangeal joints and ∆SP in the treatment group (r < 0, P < 0.05). CONCLUSION: Moxibustion combined with conventional western medicine can significantly improve PPTs in affected joints of RA patients, alleviate clinical symptoms, and reduce disease activity. The potential mechanism may be related to the down-regulation of SP and LTB4 levels and the reduction of the release of inflammatory factors Il-1β and TNF-α by moxibustion. The lack of double-blinding is a limitation of our study, which we plan to avoid by establishing a sham moxibustion group in the subsequent trials.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Tao S, Yang Y, Tang J, et al. The efficacy of moxibustion on the pressure pain threshold and substance P / leukotriene B4 contents in serum to patients with rheumatoid arthritis. Complement Ther Med. 2025. PMID: 40436210. doi:10.1016/j.ctim.2025.103187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。